Clinical trial
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive…
NCT00198055 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00198055 |
|---|---|
| Title | A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. |
| Official title | An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asperger's Disorder, Pervasive Developmental Disorder |
| Intervention type | Drug |
| Interventions | aripiprazole |
| Enrollment | 25 |
| Start date | Jan 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 4, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: